About
Technology
Issues
FAQ
Links
Official Page
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.